Autoimmune hepatitis following COVID-19 vaccination
- 5 August 2022
- journal article
- editorial
- Published by Elsevier in Journal of Autoimmunity
- Vol. 132, 102874
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injuryJournal of Hepatology, 2021
- The mRNA COVID-19 vaccine – A rare trigger of autoimmune hepatitis?Journal of Hepatology, 2021
- Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccineJournal of Hepatology, 2021
- Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?Journal of Hepatology, 2021
- Another case of autoimmune hepatitis after SARS-CoV-2 vaccination – still casualty?Journal of Hepatology, 2021
- Auto-immune hepatitis following COVID vaccinationJournal of Autoimmunity, 2021
- Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casualityJournal of Hepatology, 2021
- Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?Journal of Hepatology, 2021
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseasesClinical Immunology, 2020
- EASL Clinical Practice Guidelines: Autoimmune hepatitisJournal of Hepatology, 2015